Lung Cancers Completed Phase 2 Trials for Irinotecan (DB00762)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00387660Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung CancerTreatment
NCT00449020Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung CancerTreatment
NCT00469898Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00308529Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung CancerTreatment
NCT00193349Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung CancerTreatment
NCT00182806Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00193375Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung CancerTreatment
NCT00248482Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00104793Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung CancerTreatment
NCT00072527Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerTreatment
NCT00030433S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00005972Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung CancerTreatment
NCT00004924Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung CancerTreatment
NCT00003900Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung CancerTreatment
NCT00004139Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00003111Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerTreatment
NCT00025285Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment